TROPISM, INFECTIVITY, AND NEUTRALIZATION IN HIV
HIV 的趋向性、感染性和中和作用
基本信息
- 批准号:3748154
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
While all the determinants of tropism of HIV replication are still being
elucidated, the major determinants reside in the envelope of the virus
and are present in both the extracellular component (gp120) and the
transmembrane component (gp41). However, other genes (gag, nef, vpr,
vif) and cis-acting elements (the long terminal repeat, LTR) can also
modulate replication in different cell types. Most primary isolates,
particularly those of the NSI (non-syncytium inducing) class, fail to
replicate in established CD4-positive cell lines, although peripheral
blood mononuclear cells (PBMC) are almost always permissive even for NSI
viruses. Viruses can frequently adapt to grow in cell lines, and such
viruses have altered phenotypes. We have shown that the ELI strain of
HIV-1 adapts to replicate in H9 and U937 cells, and the changes that
confer this enhanced infectivity and expanded host range to this virus
are in both gp120 and gp41. In particular, changes were found in the
CD4-binding region of gp120 and the fusogenic region of gp41, thus
identifying these regions as important determinants for tropism in cell
lines. Concomitant with the increased infectivity was an increased
ability of the virion to bind to CD4, although CD4 binding to the variant
soluble gp120 was not affected. These results revealed that alterations
in either gp120 or gp41 in the context of the virion can affect both the
capacity of the envelope to interact with CD4 as well as infectivity,
thus indicating the importance of these regions to the functional
association of the two envelope components. To determine whether this
result is general or specific to this particular strain of HIV-1,
mutations were introduced at the corresponding position in the fusogenic
region of the LAI and MAL strains of HIV-1. The aim was to obtain a
virus with reduced replicative capacity and then by passage to obtain
revertants that had restored the infectivity. The location of the
changes in the revertants should identify interacting regions of gp41 or
120. The Leu of LAI was changed to Met and Val, and the Met of MAL was
converted to Val. Substitution of the Met with a Val eliminated the
infectivity of this virus. So far no revertants have been found. In
LAI, substitution of Met for Leu had little perceptible effect on virus
infectivity. However, replacing the Leu with Val resulted in a virus
with lower infectivity. This latter virus was found to adapt to grow on
CEM and H9 cells, and current work is engaged in determining the
nucleotide changes that account for the increased infectivity of this
virus.
尽管艾滋病毒复制取向的所有决定因素仍在
阐明,主要决定因素存在于病毒的包膜中
并存在于胞外成分(Gp120)和
跨膜成分(Gp41)。然而,其他基因(gag、nef、vpr、
Vif)和顺式作用元件(长末端重复序列,LTR)也可以
调节不同细胞类型的复制。大多数初级分离株,
尤其是NSI(非合胞体诱导)类的
在已建立的CD4阳性细胞系中复制,尽管是外周细胞
即使对于NSI,血液单个核细胞(PBMC)也几乎总是允许的
病毒。病毒可以经常适应在细胞系中生长,这样
病毒改变了表型。我们已经证明了伊利病毒株
HIV-1适应在H9和U937细胞中复制,而这种变化
使这种病毒具有更强的传染性和更大的宿主范围
在gp120和gp41中都有。特别是,在
Gp120的CD4结合区和gp41的融合区,因此
确定这些区域是细胞趋向性的重要决定因素
台词。随之而来的是传染性的增加
病毒粒子与CD_4结合的能力,尽管CD_4与变异体结合
可溶性gp120未受影响。这些结果表明,改变
在gp120或gp41中的病毒粒子的上下文中都可以影响
包膜与CD4相互作用的能力以及传染性,
从而表明这些区域对功能
两个信封组件的关联。以确定这是否
结果是针对这种特定的HIV-1毒株的一般或特定的结果,
在融合基因中的相应位置引入了突变
HIV-1的LAI和MAL毒株的区域。其目的是为了获得一种
复制能力降低的病毒,然后通过传代获得
恢复了传染性的回复变种。的位置。
反转体的变化应确定gp41或
120.赖的Leu改为Met和Val,Mal的Met是
已转换为Val。用Val替换Met消除了
这种病毒的传染性。到目前为止,还没有发现返回体。在……里面
赖氨酸、蛋氨酸替代亮氨酸对病毒作用不明显
传染性。然而,用Val替换Leu会导致病毒
传染性较低。后一种病毒被发现能够适应生长
CEM和H9细胞,目前的工作是确定
导致这种病毒传染性增加的核苷酸变化
病毒。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
K PEDEN其他文献
K PEDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('K PEDEN', 18)}}的其他基金
RELATIONSHIP BETWEEN TROPISM, INFECTIVITY, AND NEUTRALIZATION IN HIV
HIV 的趋向性、感染性和中和作用之间的关系
- 批准号:
2568928 - 财政年份:
- 资助金额:
-- - 项目类别:
USE OF ACCESSORY GENE MUTANTS FOR THE DEVELOPMENT OF ATTENUATED HIV VACCINES
使用辅助基因突变体开发减毒 HIV 疫苗
- 批准号:
3748153 - 财政年份:
- 资助金额:
-- - 项目类别:
USE OF ACCESSORY GENE MUTANTS FOR THE DEVELOPMENT OF ATTENUATED HIV VACCINES
使用辅助基因突变体开发减毒 HIV 疫苗
- 批准号:
6161247 - 财政年份:
- 资助金额:
-- - 项目类别:
DEVELOPMENT OF MOLECULAR BIOLOGICAL METHODS TO VACCINE AND CELL SUBSTRATE SAFETY
疫苗和细胞基质安全的分子生物学方法的开发
- 批准号:
6161253 - 财政年份:
- 资助金额:
-- - 项目类别:
USE OF ACCESSORY GENE MUTANTS FOR THE DEVELOPMENT OF ATTENUATED HIV VACCINES
使用辅助基因突变体开发减毒 HIV 疫苗
- 批准号:
5200718 - 财政年份:
- 资助金额:
-- - 项目类别:
A GENETIC AND BIOLOGICAL ANALYSIS OF HIV-1 AND HIV-2
HIV-1 和 HIV-2 的遗传和生物学分析
- 批准号:
3768914 - 财政年份:
- 资助金额:
-- - 项目类别:
DEVELOPMENT OF MOLECULAR BIOLOGICAL METHODS TO VACCINE AND CELL SUBSTRATE SAFETY
疫苗和细胞基质安全的分子生物学方法的开发
- 批准号:
6101188 - 财政年份:
- 资助金额:
-- - 项目类别:
RELATIONSHIP BETWEEN TROPISM, INFECTIVITY, AND NEUTRALIZATION IN HIV
HIV 的趋向性、感染性和中和作用之间的关系
- 批准号:
6161248 - 财政年份:
- 资助金额:
-- - 项目类别:
USE OF ACCESSORY GENE MUTANTS FOR THE DEVELOPMENT OF ATTENUATED HIV VACCINES
使用辅助基因突变体开发减毒 HIV 疫苗
- 批准号:
2568927 - 财政年份:
- 资助金额:
-- - 项目类别:
RELATIONSHIP BETWEEN TROPISM, INFECTIVITY, AND NEUTRALIZATION IN HIV
HIV 的趋向性、感染性和中和作用之间的关系
- 批准号:
6101183 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




